PTC Therapeutics (PTCT) Q2 2017 Earnings

8MayConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-1.28
-1.11
-0.95
-0.78

Details

Expected EPS
-1.03
Actual EPS
-0.85
Surprise EPS
0.18
Surprise Percent
+17.48%

Description

PTC Therapeutics (PTCT) has reported earnings of -0.85 per share for Q2 2017.

0 Comments

Share your thoughts